Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 MedImmune To Explore Sale | Contract Pharma

What are you searching for?

Sign in
Breaking News

MedImmune To Explore Sale

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Is MedImmune up for sale? According to a company statement, the board of directors at the company “has authorized management to evaluate whether third parties would have an interest in acquiring the company at a price and on terms that would represent a better value for its stockholders than having the company continue to execute its business plan on a stand-alone basis.”

In February, the board announced that the company was sticking to its guns, but evidently MedImmune has received “indications of interest by major pharmaceutical companies, coupled with recent expressions by certain stockholders of dissatisfaction with the company’s short-term stock price performance,” leading to the search for a possible buyer.

The company has retained the services of Goldman, Sachs & Co. and Dewey Ballantine LLP to help with the process and contends that it is “well under way,” which raises some questions with this editor about the validity of the February announcement.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters